{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:29Z","timestamp":1791296789185,"version":"4.1.0"},"reference-count":52,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1002\/ijc.30760","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T23:52:57Z","timestamp":1493855577000},"page":"572-582","source":"Crossref","is-referenced-by-count":61,"title":["Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer"],"prefix":"10.1002","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4698-2105","authenticated-orcid":false,"given":"Kostandinos","family":"Sideras","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Biermann","sequence":"additional","affiliation":[{"name":"Department of Pathology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Yap","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanta","family":"Mancham","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick P.C.","family":"Boor","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina E.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.A.","family":"Stoop","sequence":"additional","affiliation":[{"name":"Department of Pathology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel P.","family":"Peppelenbosch","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper H.","family":"van Eijck","sequence":"additional","affiliation":[{"name":"Department of Surgery; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Sleijfer","sequence":"additional","affiliation":[{"name":"Department of Oncology; Erasmus MC-University Medical Center, Erasmus MC Cancer Institute; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Kwekkeboom","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco J.","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,19]]},"reference":[{"key":"10.1002\/ijc.30760-BIB0001|ijc30760-cit-0001","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1002\/ijc.30760-BIB0002|ijc30760-cit-0002","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.30760-BIB0003|ijc30760-cit-0003","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.30760-BIB0004|ijc30760-cit-0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1002\/ijc.30760-BIB0005|ijc30760-cit-0005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature10673","article-title":"Cancer immunotherapy comes of age","volume":"480","author":"Mellman","year":"2011","journal-title":"Nature"},{"key":"10.1002\/ijc.30760-BIB0006|ijc30760-cit-0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.critrevonc.2016.03.017","article-title":"Learning from the \u201ctsunami\u201d of immune checkpoint inhibitors in 2015","volume":"101","author":"Kourie","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1002\/ijc.30760-BIB0007|ijc30760-cit-0007","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ctrv.2013.11.005","article-title":"Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies","volume":"40","author":"Sideras","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1002\/ijc.30760-BIB0008|ijc30760-cit-0008","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1002\/ijc.30760-BIB0009|ijc30760-cit-0009","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1002\/med.20249","article-title":"Therapeutic potential of Galectin-9 in human disease","volume":"33 Suppl 1","author":"Wiersma","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1002\/ijc.30760-BIB0010|ijc30760-cit-0010","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/hep.25777","article-title":"Tim-3\/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"10.1002\/ijc.30760-BIB0011|ijc30760-cit-0011","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"10.1002\/ijc.30760-BIB0012|ijc30760-cit-0012","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.175.5.2974","article-title":"Galectin-9 induces maturation of human monocyte-derived dendritic cells","volume":"175","author":"Dai","year":"2005","journal-title":"J Immunol"},{"key":"10.1002\/ijc.30760-BIB0013|ijc30760-cit-0013","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1158\/1078-0432.CCR-04-0861","article-title":"Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer","volume":"11","author":"Irie","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.30760-BIB0014|ijc30760-cit-0014","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.7314\/APJCP.2012.13.6.2503","article-title":"Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1002\/ijc.30760-BIB0015|ijc30760-cit-0015","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.coph.2012.03.001","article-title":"The HVEM network: new directions in targeting novel costimulatory\/co-inhibitory molecules for cancer therapy","volume":"12","author":"Pasero","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1002\/ijc.30760-BIB0016|ijc30760-cit-0016","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1172\/JCI40070","article-title":"BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination","volume":"120","author":"Derre","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1002\/ijc.30760-BIB0017|ijc30760-cit-0017","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-014-1687-8","article-title":"The role of IDO in brain tumor immunotherapy","volume":"123","author":"Zhai","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1002\/ijc.30760-BIB0018|ijc30760-cit-0018","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.it.2008.02.012","article-title":"A critical look at HLA-G","volume":"29","author":"Apps","year":"2008","journal-title":"Trends Immunol"},{"key":"10.1002\/ijc.30760-BIB0019|ijc30760-cit-0019","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an Immune Checkpoint Molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol"},{"key":"10.1002\/ijc.30760-BIB0020|ijc30760-cit-0020","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","article-title":"Pembrolizumab for the treatment of non-small-cell lung cancer","volume":"372","author":"Garon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.30760-BIB0021|ijc30760-cit-0021","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.30760-BIB0022|ijc30760-cit-0022","first-page":"e4059","article-title":"Immunohistochemical staining of B7-H1 (PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue","volume":"71","author":"Bigelow","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1002\/ijc.30760-BIB0023|ijc30760-cit-0023","doi-asserted-by":"crossref","first-page":"e1273309","DOI":"10.1080\/2162402X.2016.1273309","article-title":"PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma","volume":"6","author":"Sideras","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1002\/ijc.30760-BIB0024|ijc30760-cit-0024","doi-asserted-by":"crossref","first-page":"127ra37","DOI":"10.1126\/scitranslmed.3003689","article-title":"Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape","volume":"4","author":"Taube","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1002\/ijc.30760-BIB0025|ijc30760-cit-0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrd4591","article-title":"Combination cancer immunotherapy and new immunomodulatory targets","volume":"14","author":"Mahoney","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"10.1002\/ijc.30760-BIB0026|ijc30760-cit-0026","doi-asserted-by":"crossref","first-page":"e13441","DOI":"10.1371\/journal.pone.0013441","article-title":"Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor","volume":"5","author":"Tjomsland","year":"2010","journal-title":"PLoS One"},{"key":"10.1002\/ijc.30760-BIB0027|ijc30760-cit-0027","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jamcollsurg.2007.12.014","article-title":"Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection","volume":"206","author":"Witkiewicz","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1002\/ijc.30760-BIB0028|ijc30760-cit-0028","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1158\/1078-0432.CCR-06-2746","article-title":"Clinical significance and therapeutic potential of the programmed death-1 ligand\/programmed death-1 pathway in human pancreatic cancer","volume":"13","author":"Nomi","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.30760-BIB0029|ijc30760-cit-0029","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00268-010-0448-x","article-title":"Clinical significance of B7-H1 and B7-1 expressions in pancreatic carcinoma","volume":"34","author":"Wang","year":"2010","journal-title":"World J Surg"},{"key":"10.1002\/ijc.30760-BIB0030|ijc30760-cit-0030","first-page":"2036","article-title":"HLA-G impairs host immune response and predicts poor prognosis in pancreatic cancer","volume":"7","author":"Zhou","year":"2015","journal-title":"Am J Transl Res"},{"key":"10.1002\/ijc.30760-BIB0031|ijc30760-cit-0031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/1566524015666150401102218","article-title":"High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC","volume":"15","author":"Xu","year":"2015","journal-title":"Curr Mol Med"},{"key":"10.1002\/ijc.30760-BIB0032|ijc30760-cit-0032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/IJGC:35:1:015","article-title":"HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract","volume":"35","author":"Hansel","year":"2005","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1002\/ijc.30760-BIB0033|ijc30760-cit-0033","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.30760-BIB0034|ijc30760-cit-0034","doi-asserted-by":"crossref","first-page":"200ra116","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1002\/ijc.30760-BIB0035|ijc30760-cit-0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jhep.2006.05.007","article-title":"PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis","volume":"45","author":"Muhlbauer","year":"2006","journal-title":"J Hepatol"},{"key":"10.1002\/ijc.30760-BIB0036|ijc30760-cit-0036","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4049\/jimmunol.1100164","article-title":"Activated CD69+ T cells foster immune privilege by regulating IDO expression in tumor-associated macrophages","volume":"188","author":"Zhao","year":"2012","journal-title":"J Immunol"},{"key":"10.1002\/ijc.30760-BIB0037|ijc30760-cit-0037","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-15-0255","article-title":"Classifying Cancers Based on T-cell Infiltration and PD-L1","volume":"75","author":"Teng","year":"2015","journal-title":"Cancer Res"},{"key":"10.1002\/ijc.30760-BIB0038|ijc30760-cit-0038","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1002\/cncr.25747","article-title":"Overall survival and PD-L1 expression in metastasized malignant melanoma","volume":"117","author":"Gadiot","year":"2011","journal-title":"Cancer"},{"key":"10.1002\/ijc.30760-BIB0039|ijc30760-cit-0039","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/labinvest.2013.130","article-title":"Programmed death ligand-1 expression in non-small cell lung cancer","volume":"94","author":"Velcheti","year":"2014","journal-title":"Lab Invest"},{"key":"10.1002\/ijc.30760-BIB0040|ijc30760-cit-0040","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/2326-6066.CIR-15-0116","article-title":"PD-L1 Antibodies to Its Cytoplasmic Domain Most Clearly Delineate Cell Membranes in Immunohistochemical Staining of Tumor Cells","volume":"3","author":"Mahoney","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1002\/ijc.30760-BIB0041|ijc30760-cit-0041","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.humimm.2003.10.005","article-title":"The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes","volume":"65","author":"Polakova","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1002\/ijc.30760-BIB0042|ijc30760-cit-0042","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-0039.2012.01922.x","article-title":"Reassessment of HLA-G isoform specificity of MEM-G\/9 and 4H84 monoclonal antibodies","volume":"80","author":"Zhao","year":"2012","journal-title":"Tissue Antigens"},{"key":"10.1002\/ijc.30760-BIB0043|ijc30760-cit-0043","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1073\/pnas.212643199","article-title":"Disulfide bond-mediated dimerization of HLA-G on the cell surface","volume":"99","author":"Boyson","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/ijc.30760-BIB0044|ijc30760-cit-0044","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0039.2003.00143.x","article-title":"Biology and functions of human leukocyte antigen-G in health and sickness","volume":"62","author":"LeMaoult","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1002\/ijc.30760-BIB0045|ijc30760-cit-0045","doi-asserted-by":"crossref","first-page":"71198","DOI":"10.18632\/oncotarget.11685","article-title":"Prognostic value of PDL1 expression in pancreatic cancer","volume":"7","author":"Birnbaum","year":"2016","journal-title":"Oncotarget"},{"key":"10.1002\/ijc.30760-BIB0046|ijc30760-cit-0046","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00432-008-0364-8","article-title":"B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression","volume":"134","author":"Geng","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1002\/ijc.30760-BIB0047|ijc30760-cit-0047","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1002\/ijc.30760-BIB0048|ijc30760-cit-0048","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0902-1039c","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"10.1002\/ijc.30760-BIB0049|ijc30760-cit-0049","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00428-016-1910-4","article-title":"Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients","volume":"468","author":"Ilie","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1002\/ijc.30760-BIB0050|ijc30760-cit-0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3389\/fimmu.2014.00619","article-title":"Diverse mechanisms regulate the surface expression of immunotherapeutic target ctla-4","volume":"5","author":"Schneider","year":"2014","journal-title":"Front Immunol"},{"key":"10.1002\/ijc.30760-BIB0051|ijc30760-cit-0051","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.4049\/jimmunol.157.11.4762","article-title":"Regulation of surface and intracellular expression of CTLA4 on mouse T cells","volume":"157","author":"Alegre","year":"1996","journal-title":"J Immunol"},{"key":"10.1002\/ijc.30760-BIB0052|ijc30760-cit-0052","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.30760","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/ijc.30760\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T11:52:33Z","timestamp":1692791553000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.30760"}},"subtitle":["Immune inhibitory molecules in pancreatic and ampullary cancer"],"short-title":[],"issued":{"date-parts":[[2017,5,19]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.30760","archive":["Portico"],"relation":{},"ISSN":["0020-7136"],"issn-type":[{"value":"0020-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5,19]]}}}